Gene expression signatures identify novel therapeutics for metastatic pancreatic neuroendocrine tumors

AT Scott, M Weitz, PJ Breheny, PH Ear, B Darbro… - Clinical cancer …, 2020 - AACR
Purpose: Pancreatic neuroendocrine tumors (pNETs) are uncommon malignancies noted for
their propensity to metastasize and comparatively favorable prognosis. Although both the …
被引用次数：44 相关文章
[PDF] academia.edu

[PDF][PDF] Gene Expression Signatures Identify Novel Therapeutics for Metastatic Pancreatic Neuroendocrine Tumors

AT Scott, M Weitz, PJ Breheny, PH Ear, BW Darbro… - academia.edu
Conclusions We employed a complementary bioinformatics approach to identify novel
therapeutics for pNETs by analyzing gene expression in metastatic tumors. The potential …
[HTML] nih.gov

[HTML][HTML] Gene Expression Signatures Identify Novel Therapeutics for Metastatic Pancreatic Neuroendocrine Tumors

AT Scott, M Weitz, PJ Breheny, PH Ear… - … cancer research: an …, 2020 - ncbi.nlm.nih.gov
Purpose Pancreatic neuroendocrine tumors (pNETs) are uncommon malignancies noted for
their propensity to metastasize and comparatively favorable prognosis. Although both the …

Gene Expression Signatures Identify Novel Therapeutics for Metastatic Pancreatic Neuroendocrine Tumors

AT Scott, M Weitz, PJ Breheny… - … : an official journal …, 2020 - pubmed.ncbi.nlm.nih.gov
Purpose Pancreatic neuroendocrine tumors (pNETs) are uncommon malignancies noted for
their propensity to metastasize and comparatively favorable prognosis. Although both the …

Gene Expression Signatures Identify Novel Therapeutics for Metastatic Pancreatic Neuroendocrine Tumors

AT Scott, M Weitz, PJ Breheny, PH Ear… - Clinical cancer …, 2020 - iro.uiowa.edu
Pancreatic neuroendocrine tumors (pNETs) are uncommon malignancies noted for their
propensity to metastasize and comparatively favorable prognosis. Although both the …

Gene Expression Signatures Identify Novel Therapeutics for Metastatic Pancreatic Neuroendocrine Tumors.

AT Scott, M Weitz, PJ Breheny, PH Ear… - … Cancer Research: an …, 2020 - europepmc.org
Purpose Pancreatic neuroendocrine tumors (pNETs) are uncommon malignancies noted for
their propensity to metastasize and comparatively favorable prognosis. Although both the …

Gene Expression Signatures Identify Novel Therapeutics for Metastatic Pancreatic Neuroendocrine Tumors.

AT Scott, M Weitz, PJ Breheny, PH Ear… - … Cancer Research: an …, 2020 - europepmc.org
Purpose Pancreatic neuroendocrine tumors (pNETs) are uncommon malignancies noted for
their propensity to metastasize and comparatively favorable prognosis. Although both the …

Gene Expression Signatures Identify Novel Therapeutics for Metastatic Pancreatic Neuroendocrine Tumors

AT Scott, M Weitz, PJ Breheny, PH Ear… - Clinical cancer …, 2020 - iro.uiowa.edu
Pancreatic neuroendocrine tumors (pNETs) are uncommon malignancies noted for their
propensity to metastasize and comparatively favorable prognosis. Although both the …